Quick Answer
Petros Pharmaceuticals, Inc. reported Total Revenue of $5.99 million for fiscal year 2022.
Petros Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2022 | $5.99M | -23.3% |
| 2021 | $7.81M | -18.3% |
| 2020 | $9.56M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | $1.99M | -52.4% | -20.8% |
| March 31, 2023 | $2.52M | +2.1% | -39.9% |
| June 30, 2022 | $4.19M | +70.3% | +69.8% |
| March 31, 2022 | $2.47M | -39.5% | +14.9% |
| September 30, 2021 | $2.15M | -38.1% | -12.7% |
| June 30, 2021 | $2.46M | +78.9% | -39.7% |
| March 31, 2021 | $4.08M | +127.4% | +17.6% |
| September 30, 2020 | $3.46M | — | +152.2% |
- Petros Pharmaceuticals, Inc. showed a decrease of -23.3% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2022 period, Petros Pharmaceuticals, Inc.’s total revenue has declined by 37.3% (from $9.56 million to $5.99 million).
- The most recent figure is from Petros Pharmaceuticals, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 31, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: